📰 Pierer Mobility News
Page 7 - Pierer Mobility News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Pierer Mobility. Real-time updates on events, politics, business and more.
January 15, 2023
21st Austria weekly - Strabag Pierer Mobility 09/01/2023 [pic1]Strabag: Klemens Haselsteiner is the new Chief Executive Officer of construction group Strabag SE. With effect from 1 January 2023 he takes over post Thomas Birtel who has reached maximum age limit after ten years in office. been with Group and held various management positions since 2011. He says: “These are challenging times we living in. The
January 9, 2023
09.01.2023 - EQS-Ad-hoc: PIERER Mobility AG / Key word(s): Miscellaneous/Forecast PIERER Mobility AG: Another record year in 2022 and positive outlook for 2023 09-Jan-2023 / 18:24 CET/CEST Disclosure of an inside information acc. to Article 17 MAR of the ... Seite 1
January 1, 2023
21st Austria weekly - Remembering 2022 31/12/2022 [pic1]The last week of the year brought a slightly weaker ATX TR. News came from Erste Group Marinomed Semperit Pierer Mobility S Immo Kontron Immofinanz Valneva Vienna
January 1, 2023
21st Austria weekly - Valneva Vienna Stock Exchange 30/12/2022 [pic1]Valneva: an Austrian/French specialty vaccine company reported further heterologous booster data from exploratory small clinical study for its inactivated COVID-19 vaccine VLA2001. The show that a dose of VLA2001 was well tolerated in previously BNT162b2 Pfizer/BioNTech- or mRNA 1273 Moderna-vaccinated participants confirming the favorable safety profile seen across all studies – including homologous settings. Ho...
January 1, 2023
21st Austria weekly - Marinomed Semperit Pierer Mobility 27/12/2022 [pic1]Marinomed Biotech: Marinomed Biotech AG listed on the Vienna Stock Exchange VSE:MARI announced that United States Patent and Trademark Office has granted patent US11510859 covering Marinosolv
January 1, 2023
21st Austria weekly - Valneva Vienna Stock Exchange 30/12/2022 [pic1]Valneva: an Austrian/French specialty vaccine company reported further heterologous booster data from exploratory small clinical study for its inactivated COVID-19 vaccine VLA2001. The show that a dose of VLA2001 was well tolerated in previously BNT162b2 Pfizer/BioNTech- or mRNA 1273 Moderna-vaccinated participants confirming the favorable safety profile seen across all studies – including homologous settings. Ho...
January 1, 2023
21st Austria weekly - Valneva Vienna Stock Exchange 30/12/2022 [pic1]Valneva: an Austrian/French specialty vaccine company reported further heterologous booster data from exploratory small clinical study for its inactivated COVID-19 vaccine VLA2001. The show that a dose of VLA2001 was well tolerated in previously BNT162b2 Pfizer/BioNTech- or mRNA 1273 Moderna-vaccinated participants confirming the favorable safety profile seen across all studies – including homologous settings. Ho...
January 1, 2023
21st Austria weekly - Valneva Vienna Stock Exchange 30/12/2022 [pic1]Valneva: an Austrian/French specialty vaccine company reported further heterologous booster data from exploratory small clinical study for its inactivated COVID-19 vaccine VLA2001. The show that a dose of VLA2001 was well tolerated in previously BNT162b2 Pfizer/BioNTech- or mRNA 1273 Moderna-vaccinated participants confirming the favorable safety profile seen across all studies – including homologous settings. Ho...
December 30, 2022
<p><span>A changing inflation and interest rate environment, the Russian attack on Ukraine and the ongoing energy crisis weighed on European stock markets in 2022. With a forecast of EUR 72 billion, trading participants on the Vienna Stock Exchange generated roughly the same turnover as in the strong previous year. The primary market was challenging. With Pierer Mobility AG and RHI Magnesita N.V., the prime market grew to 40 companies. In the SME segment, VAS AG from Salzburg made it...
December 28, 2022
Austrian motorcycle conglomerate Pierer Mobility, through its North American arm, is bringing GASGAS electric mountain bikes to the U.S. market by 2023.